Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-3039-1
Published Online: 2016-04-22
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fujii, Hironori
Iihara, Hirotoshi
Suzuki, Akio
Kobayashi, Ryo
Matsuhashi, Nobuhisa
Takahashi, Takao
Yoshida, Kazuhiro
Itoh, Yoshinori
Text and Data Mining valid from 2016-04-22